These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20560004)

  • 1. Hypertrophic cardiomyopathy: preclinical and early phenotype.
    Ho CY
    J Cardiovasc Transl Res; 2009 Dec; 2(4):462-70. PubMed ID: 20560004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].
    Ho CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):289-93. PubMed ID: 19791460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic
    Parbhudayal RY; Harms HJ; Michels M; van Rossum AC; Germans T; van der Velden J
    J Am Heart Assoc; 2020 Apr; 9(8):e015316. PubMed ID: 32290750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
    Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
    Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
    Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
    JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.
    Chang SA; Lee SC; Choe YH; Hahn HJ; Jang SY; Park SJ; Choi JO; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Dec; 28 Suppl 2():133-40. PubMed ID: 23097128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
    Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
    Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
    Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
    J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
    Ho CY; Carlsen C; Thune JJ; Havndrup O; Bundgaard H; Farrohi F; Rivero J; Cirino AL; Andersen PS; Christiansen M; Maron BJ; Orav EJ; Køber L
    Circ Cardiovasc Genet; 2009 Aug; 2(4):314-21. PubMed ID: 20031602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
    Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
    Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.
    Michels M; Soliman OI; Kofflard MJ; Hoedemaekers YM; Dooijes D; Majoor-Krakauer D; ten Cate FJ
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):58-64. PubMed ID: 19356534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in
    Salazar-Mendiguchía J; Ochoa JP; Palomino-Doza J; Domínguez F; Díez-López C; Akhtar M; Ramiro-León S; Clemente MM; Pérez-Cejas A; Robledo M; Gómez-Díaz I; Peña-Peña ML; Climent V; Salmerón-Martínez F; Hernández C; García-Granja PE; Mogollón MV; Cárdenas-Reyes I; Cicerchia M; García-Giustiniani D; Lamounier A; Gil-Fournier B; Díaz-Flores F; Salguero R; Santomé L; Syrris P; Olivé M; García-Pavía P; Ortiz-Genga M; Elliott PM; Monserrat L;
    Heart; 2020 Sep; 106(17):1342-1348. PubMed ID: 32451364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.
    Reant P; Captur G; Mirabel M; Nasis A; M Sado D; Maestrini V; Castelletti S; Manisty C; Herrey AS; Syrris P; Tome-Esteban M; Jenkins S; Elliott PM; McKenna WJ; Moon JC
    J Cardiovasc Magn Reson; 2015 Jul; 17(1):64. PubMed ID: 26219660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomyocardial radial strain imaging and left ventricular relaxation abnormalities in patients with hypertrophic cardiomyopathy or hypertensive left ventricular hypertrophy.
    Minoshima M; Noda A; Nishizawa T; Hara Y; Sugiura M; Iino S; Nagata K; Koike Y; Murohara T
    Circ J; 2009 Dec; 73(12):2294-9. PubMed ID: 19838000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
    Lakdawala NK; Thune JJ; Maron BJ; Cirino AL; Havndrup O; Bundgaard H; Christiansen M; Carlsen CM; Dorval JF; Kwong RY; Colan SD; Køber LV; Ho CY
    Am J Cardiol; 2011 Dec; 108(11):1606-13. PubMed ID: 21943931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.